Laboratory & clinical services at the Peter Mac's Therapeutic Goods Administration licensed facilities

Who Are Cell Therapies

Cell Therapies, through the Centre for Blood Cell Therapies, provides clients and collaborators with a focused business unit, able to negotiate and execute all commercial aspects of for-fees engagements

Dr Dominic Wall is the Production Manager for the Centre for Blood Cell Therapies (CBCT) and is the production nominee cited for the purposes of licensing by the Therapeutics Good Administration.

More about Dominic Wall |

Ray is the Managing Director of Cell Therapies Pty Ltd the commercial entity specifically created to capture the value inherent in Peter Mac's Center for Blood Cell Therapies.

More about Ray Wood |

A special purpose and independent company that manages the commercial interface to Peter Mac’s licensed manufacturing resources

In 1996, the Peter MacCallum Cancer Centre established the Centre for Blood Cell Therapies (CBCT) to support a range of activities involving cell and tissue manipulation under conditions that would meet the requirements of the code of current Good Manufacturing Practice (cGMP). We describe the principles and practicalities of developing a cGMP-compliant cell processing/ engineering center (CPC) capable of manipulating and processing human cells for clinical trials and related commercial activities.

The Peter MacCallum Cancer Centre www.petermac.org/research and its Centre for Blood Cell Therapies (CBCT) have, for some time been undertaking fee-based clinical trials involving cell and tissue manipulation under cGMP and regulated manufacturing conditions.

Cell Therapies Pty Ltd is a special purpose and independent company set up to manage the commercial interface to Peter Mac’s licensed manufacturing resources.